200 related articles for article (PubMed ID: 38389404)
1. Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines.
Yoo JG; Lee SJ; Nam EJ; No JH; Park JY; Song JY; Shin SJ; Yun BS; Park ST; Lee SH; Suh DH; Kim YB; Lee TS; Bae JM; Lee KH
J Gynecol Oncol; 2024 Mar; 35(2):e44. PubMed ID: 38389404
[TBL] [Abstract][Full Text] [Related]
2. No. 370-Management of Squamous Cell Cancer of the Vulva.
Francis JA; Eiriksson L; Dean E; Sebastianelli A; Bahoric B; Salvador S
J Obstet Gynaecol Can; 2019 Jan; 41(1):89-101. PubMed ID: 30580832
[TBL] [Abstract][Full Text] [Related]
3. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement.
Kim JH; Kim DY; Kim J; Noh JJ; Hwang WY; Baek MH; Choi MC; Joo WD; Lee YJ; Suh DH; Kim YB
J Gynecol Oncol; 2024 Mar; 35(2):e45. PubMed ID: 38216137
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of PD-1 inhibitor combined with concurrent chemoradiotherapy in locally advanced cervical cancer with pelvic and/or para-aortic lymph node metastases: a retrospective cohort study.
Liu C; Ran X; Wang Z; Zhang K
Chin Clin Oncol; 2023 Aug; 12(4):38. PubMed ID: 37699603
[TBL] [Abstract][Full Text] [Related]
5. Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position statement.
Kim M; Kong TW; Kim S; Kim SC; Kim YB; Kim JW; Park JY; Suh DH; Shim SH; Lee KH; Lee SJ; Lee JK; Lim MC
J Gynecol Oncol; 2019 Sep; 30(5):e104. PubMed ID: 31328466
[TBL] [Abstract][Full Text] [Related]
6. Novel Surgical Strategies in the Treatment of Gynecological Malignancies.
Angeles MA; Martínez-Gómez C; Migliorelli F; Voglimacci M; Figurelli J; Motton S; Tanguy Le Gac Y; Ferron G; Martinez A
Curr Treat Options Oncol; 2018 Nov; 19(12):73. PubMed ID: 30411170
[TBL] [Abstract][Full Text] [Related]
7. Robotic-assisted minimally invasive surgery for gynecologic and urologic oncology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(27):1-118. PubMed ID: 23074405
[TBL] [Abstract][Full Text] [Related]
8. Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies.
Rossi EC; Tanner E
J Minim Invasive Gynecol; 2021 Mar; 28(3):409-417. PubMed ID: 33359741
[TBL] [Abstract][Full Text] [Related]
9. Practice guidelines for management of cervical cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
Lim MC; Lee M; Shim SH; Nam EJ; Lee JY; Kim HJ; Lee YY; Lee KB; Park JY; Kim YH; Ki KD; Song YJ; Chung HH; Kim S; Lee JW; Kim JW; Bae DS; Lee JM
J Gynecol Oncol; 2017 May; 28(3):e22. PubMed ID: 28382794
[TBL] [Abstract][Full Text] [Related]
10. Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer.
Ebina Y; Mikami M; Nagase S; Tabata T; Kaneuchi M; Tashiro H; Mandai M; Enomoto T; Kobayashi Y; Katabuchi H; Yaegashi N; Udagawa Y; Aoki D
Int J Clin Oncol; 2019 Jan; 24(1):1-19. PubMed ID: 30291468
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative surgical algorithm: sentinel lymph node biopsy as predictor of parametrial involvement in early-stage cervical cancer.
Balaya V; Bresset A; Guani B; Benoit L; Magaud L; Bonsang-Kitzis H; Ngo C; Mathevet P; Lécuru F;
Int J Gynecol Cancer; 2020 Sep; 30(9):1317-1325. PubMed ID: 32753560
[TBL] [Abstract][Full Text] [Related]
12. Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Lyman GH; Temin S; Edge SB; Newman LA; Turner RR; Weaver DL; Benson AB; Bosserman LD; Burstein HJ; Cody H; Hayman J; Perkins CL; Podoloff DA; Giuliano AE;
J Clin Oncol; 2014 May; 32(13):1365-83. PubMed ID: 24663048
[TBL] [Abstract][Full Text] [Related]
13. [Expert consensus on clinical application of sentinel lymph node biopsy for cervical cancer].
Obstetrics and Gynecology Committee of Chinese Research Hospital Association
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):981-988. PubMed ID: 34695887
[TBL] [Abstract][Full Text] [Related]
14. Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
Seino M; Nagase S; Tokunaga H; Yamagami W; Kobayashi Y; Tabata T; Kaneuchi M; Hirashima Y; Niikura H; Yoshino K; Takehara K; Baba T; Katabuchi H; Mikami M
J Gynecol Oncol; 2024 Jan; 35(1):e15. PubMed ID: 38037547
[TBL] [Abstract][Full Text] [Related]
15. The Oncological Implication of Sentinel Lymph Node in Early Cervical Cancer: A Meta-Analysis of Oncological Outcomes and Type of Recurrences.
Ronsini C; De Franciscis P; Carotenuto RM; Pasanisi F; Cobellis L; Colacurci N
Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363496
[No Abstract] [Full Text] [Related]
16. No. 385-Indications for Pelvic Examination.
Evans D; Goldstein S; Loewy A; Altman AD
J Obstet Gynaecol Can; 2019 Aug; 41(8):1221-1234. PubMed ID: 31331610
[TBL] [Abstract][Full Text] [Related]
17. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement.
Lee SW; Lee TS; Hong DG; No JH; Park DC; Bae JM; Seong SJ; Shin SJ; Ju W; Lee KH; Lee YK; Cho H; Lee C; Paek J; Kim HJ; Lee JW; Kim JW; Bae DS
J Gynecol Oncol; 2017 Jan; 28(1):e12. PubMed ID: 27894165
[TBL] [Abstract][Full Text] [Related]
18. The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee.
Ikeda M; Shida M; Shigeta S; Nagase S; Takahashi F; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
J Gynecol Oncol; 2021 May; 32(3):e44. PubMed ID: 33825359
[TBL] [Abstract][Full Text] [Related]
19. Major clinical research advances in gynecologic cancer in 2018.
Kim M; Suh DH; Lee KH; Eom KY; Toftdahl NG; Mirza MR; Kim JW
J Gynecol Oncol; 2019 Mar; 30(2):e18. PubMed ID: 30806045
[TBL] [Abstract][Full Text] [Related]
20. Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.
Cao L; Wen H; Feng Z; Han X; Zhu J; Wu X
Int J Gynecol Cancer; 2021 Jan; 31(1):52-58. PubMed ID: 33303568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
